Date   Headline
Dec 11, 2019 Celcuity Presents Results at the 2019 San Antonio Breast Cancer Symposium Evaluating a Sub-Group of PIK3CA WT Breast Cancer Patients Who Have Hyperactive Signaling Tumors Responsive to PI3K Inhibitors
Dec 5, 2019 Celcuity Announces Appointment of Richard Buller to Board of Directors
Nov 7, 2019 Celcuity Reports Third Quarter 2019 Financial Results
Oct 24, 2019 Celcuity Inc. Schedules Release of Third Quarter 2019 Financial Results and Conference Call
Sep 9, 2019 Celcuity Announces Appointment of Eric Lindquist as Chief Business Officer
Aug 8, 2019 Celcuity Reports Second Quarter 2019 Financial Results
Jul 25, 2019 Celcuity Inc. Schedules Release of Second Quarter 2019 Financial Results and Conference Call
May 20, 2019 Celcuity Announces Appointment of Leo Furcht to Board of Directors
May 7, 2019 Celcuity Reports First Quarter 2019 Financial Results
Apr 23, 2019 Celcuity Inc. Schedules Release of First Quarter 2019 Financial Results and Conference Call
Feb 26, 2019 Celcuity Reports Fourth Quarter and Full Year 2018 Financial Results
Feb 14, 2019 Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2018 Financial Results and Conference Call
Dec 7, 2018 Celcuity Presents Results from Three Studies at the 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with Hyperactive and Co-Activated HER Family and c-Met Signaling
Nov 13, 2018 Celcuity Reports Third Quarter 2018 Financial Results
Oct 30, 2018 Celcuity Inc. Schedules Release of Third Quarter 2018 Financial Results and Conference Call